sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks Salermide

Salermide

CAS No.:
1105698-15-4
Catalog Number:
AG008SSH
Molecular Formula:
C26H22N2O2
Molecular Weight:
394.4651
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
≥98%
1 week
United States
$112
- +
10mg
≥98%
1 week
United States
$162
- +
25mg
98%
1 week
United States
$307
- +
50mg
98%
1 week
United States
$490
- +
100mg
98%
1 week
United States
$823
- +
Product Description
Catalog Number:
AG008SSH
Chemical Name:
Salermide
CAS Number:
1105698-15-4
Molecular Formula:
C26H22N2O2
Molecular Weight:
394.4651
MDL Number:
MFCD12912446
IUPAC Name:
N-[3-[(2-hydroxynaphthalen-1-yl)methylideneamino]phenyl]-2-phenylpropanamide
InChI:
InChI=1S/C26H22N2O2/c1-18(19-8-3-2-4-9-19)26(30)28-22-12-7-11-21(16-22)27-17-24-23-13-6-5-10-20(23)14-15-25(24)29/h2-18,29H,1H3,(H,28,30)
InChI Key:
HQSSEGBEYORUBY-UHFFFAOYSA-N
SMILES:
O=C(C(c1ccccc1)C)Nc1cccc(c1)NC=C1C(=O)C=Cc2c1cccc2
Properties
Complexity:
586  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
394.168g/mol
Formal Charge:
0
Heavy Atom Count:
30  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
394.474g/mol
Monoisotopic Mass:
394.168g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
61.7A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
5.5  
Literature
Title Journal
Antiasthmatic effects of resveratrol in ovalbumin-induced asthma model mice involved in the upregulation of PTEN. Biological & pharmaceutical bulletin 20150101
Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle. Vascular pharmacology 20120101
SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2. Molecular cancer therapeutics 20100401
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect. Oncogene 20090212
Properties